14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.58 $2.30 Thursday, 25th Apr 2024 CTMX stock ended at $1.60. This is 1.84% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 3.54% from a day low at $1.58 to a day high of $1.64.
90 days $1.38 $2.86
52 weeks $1.04 $2.86

Historical CytomX Therapeutics prices

Date Open High Low Close Volume
Sep 25, 2020 $6.56 $6.88 $6.50 $6.80 506 699
Sep 24, 2020 $6.57 $6.75 $6.38 $6.56 483 827
Sep 23, 2020 $6.78 $6.97 $6.58 $6.61 364 222
Sep 22, 2020 $6.65 $6.84 $6.41 $6.72 551 561
Sep 21, 2020 $7.21 $7.21 $6.85 $6.94 546 370
Sep 18, 2020 $7.27 $7.46 $7.04 $7.40 898 893
Sep 17, 2020 $7.21 $7.29 $7.04 $7.18 267 058
Sep 16, 2020 $7.32 $7.54 $7.24 $7.33 363 627
Sep 15, 2020 $7.29 $7.46 $7.17 $7.22 515 922
Sep 14, 2020 $6.85 $7.26 $6.82 $7.18 1 548 200
Sep 11, 2020 $6.97 $7.08 $6.67 $6.73 699 138
Sep 10, 2020 $6.84 $6.99 $6.81 $6.86 627 428
Sep 09, 2020 $6.65 $6.92 $6.63 $6.82 289 314
Sep 08, 2020 $6.47 $6.79 $6.40 $6.62 386 776
Sep 04, 2020 $6.74 $6.83 $6.25 $6.56 362 198
Sep 03, 2020 $7.14 $7.14 $6.68 $6.68 377 926
Sep 02, 2020 $7.02 $7.34 $6.98 $7.19 428 650
Sep 01, 2020 $7.26 $7.32 $7.00 $7.02 331 982
Aug 31, 2020 $7.11 $7.34 $6.94 $7.30 634 011
Aug 28, 2020 $7.04 $7.15 $6.93 $7.14 397 555
Aug 27, 2020 $7.04 $7.12 $6.92 $7.05 189 986
Aug 26, 2020 $7.10 $7.19 $6.96 $7.03 262 069
Aug 25, 2020 $6.86 $7.15 $6.77 $7.08 366 823
Aug 24, 2020 $7.00 $7.21 $6.80 $6.85 348 624
Aug 21, 2020 $7.15 $7.32 $6.92 $6.95 363 750
Click to get the best stock tips daily for free!

About CytomX Therapeutics

CytomX Therapeutics CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical trials for the treatment of breast cancer; CX-2029 that is in Phase II clinical trials for the treatme... CTMX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT